Works matching DE "AIDS vaccines"
Results: 1466
CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadth.
- Published in:
- PLoS Pathogens, 2025, v. 21, n. 1, p. 1, doi. 10.1371/journal.ppat.1012916
- By:
- Publication type:
- Article
Conserved structural elements in the V3 crown of HIV-1 gp120.
- Published in:
- Nature Structural & Molecular Biology, 2010, v. 17, n. 8, p. 955, doi. 10.1038/nsmb.1861
- By:
- Publication type:
- Article
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Towards a coronavirus-based HIV multigene vaccine.
- Published in:
- Clinical & Developmental Immunology, 2006, v. 13, n. 2-4, p. 353, doi. 10.1080/17402520600579168
- By:
- Publication type:
- Article
In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate.
- Published in:
- Biotechnology Letters, 2021, v. 43, n. 3, p. 547, doi. 10.1007/s10529-020-03060-3
- By:
- Publication type:
- Article
Design and in vitro delivery of HIV-1 multi-epitope DNA and peptide constructs using novel cell-penetrating peptides.
- Published in:
- Biotechnology Letters, 2019, v. 41, n. 11, p. 1283, doi. 10.1007/s10529-019-02734-x
- By:
- Publication type:
- Article
Subcutaneous administration CpG-ODNs acts as a potent adjuvant for an HIV-1-<italic>tat</italic>-based vaccine candidate to elicit cellular immunity in BALB/c mice.
- Published in:
- Biotechnology Letters, 2018, v. 40, n. 3, p. 527, doi. 10.1007/s10529-017-2497-9
- By:
- Publication type:
- Article
Convergence in peptide folding simulation: Multiple trajectories of a potential AIDS pharmacophore.
- Published in:
- Biopolymers, 2003, v. 70, n. 2, p. 121, doi. 10.1002/bip.10401
- By:
- Publication type:
- Article
Army HIV vaccine to undergo clinical trial a rival is halted.
- Published in:
- Nature, 2002, v. 416, n. 6876, p. 6, doi. 10.1038/416006a
- By:
- Publication type:
- Article
On the trail of two trials.
- Published in:
- Nature, 2002, v. 415, n. 6870, p. 365, doi. 10.1038/415365a
- By:
- Publication type:
- Article
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
- Published in:
- Nature, 2002, v. 415, n. 6869, p. 335, doi. 10.1038/415335a
- By:
- Publication type:
- Article
One step forwards, one step back.
- Published in:
- Nature, 2002, v. 415, n. 6869, p. 272, doi. 10.1038/415272b
- By:
- Publication type:
- Article
Vaccine centres unite specialists in the battle against infectious diseases.
- Published in:
- Nature, 2000, v. 408, n. 6813, p. 753, doi. 10.1038/35047215
- By:
- Publication type:
- Article
Kenyans protest at being left off AIDS patent.
- Published in:
- Nature, 2000, v. 408, n. 6808, p. 6, doi. 10.1038/35040724
- By:
- Publication type:
- Article
Bacterial AIDS vaccine ready for testing.
- Published in:
- Nature, 2000, v. 405, n. 6785, p. 386, doi. 10.1038/35013229
- By:
- Publication type:
- Article
Call for governments to back development of AIDS vaccine.
- Published in:
- Nature, 1999, v. 401, n. 6748, p. 4, doi. 10.1038/43248
- By:
- Publication type:
- Article
News in brief.
- Published in:
- Nature, 1999, v. 399, n. 6733, p. 192, doi. 10.1038/20284
- Publication type:
- Article
US quest for AIDS vaccine appoints a leader.
- Published in:
- Nature, 1999, v. 398, n. 6724, p. 180
- By:
- Publication type:
- Article
India agrees to conduct AIDS vaccine trials.
- Published in:
- Nature, 1998, v. 396, n. 6707, p. 102, doi. 10.1038/24001
- By:
- Publication type:
- Article
NIH Institute to work with trial of AIDS vaccine, despite concerns.
- Published in:
- Nature, 1998, v. 394, n. 6696, p. 818, doi. 10.1038/29604
- By:
- Publication type:
- Article
Clinton `is failing to honour pledge on AIDS vaccine.'
- Published in:
- Nature, 1998, v. 393, n. 6682, p. 199, doi. 10.1038/30305
- By:
- Publication type:
- Article
Ex-UN AIDS chief is blasted for remarks on vaccine strategy.
- Published in:
- Nature, 1998, v. 392, n. 6676, p. 527, doi. 10.1038/33206
- By:
- Publication type:
- Article
Viral envelope fails to deliver?
- Published in:
- Nature, 1998, v. 391, n. 6668, p. 638, doi. 10.1038/35504
- By:
- Publication type:
- Article
US dispute over live AIDS vaccine trials.
- Published in:
- Nature, 1997, v. 389, n. 6650, p. 426, doi. 10.1038/38823
- By:
- Publication type:
- Article
Advances encourage Nobel winner to head AIDS vaccine effort.
- Published in:
- Nature, 1996, v. 384, n. 6610, p. 604, doi. 10.1038/384604c0
- By:
- Publication type:
- Article
Prediction of HIV sensitivity to monoclonal antibodies using aminoacid sequences and deep learning.
- Published in:
- Bioinformatics, 2022, v. 38, n. 18, p. 4278, doi. 10.1093/bioinformatics/btac530
- By:
- Publication type:
- Article
Sub-dominant principal components inform new vaccine targets for HIV Gag.
- Published in:
- Bioinformatics, 2019, v. 35, n. 20, p. 3884, doi. 10.1093/bioinformatics/btz524
- By:
- Publication type:
- Article
HIITE: HIV-1 incidence and infection time estimator.
- Published in:
- Bioinformatics, 2018, v. 34, n. 12, p. 2046, doi. 10.1093/bioinformatics/bty073
- By:
- Publication type:
- Article
SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials.
- Published in:
- Bioinformatics, 2017, v. 33, n. 15, p. 2386, doi. 10.1093/bioinformatics/btx168
- By:
- Publication type:
- Article
Fauci Versus Viruses and Trump.
- Published in:
- GEN Biotechnology, 2024, v. 3, n. 6, p. 333, doi. 10.1089/genbio.2024.0060
- By:
- Publication type:
- Article
Lessons learned from HIV-1 vaccine trials: new priorities and directions.
- Published in:
- Nature Immunology, 2013, v. 14, n. 4, p. 413, doi. 10.1038/ni0413-413a
- By:
- Publication type:
- Article
HIV vaccine design: insights from live attenuated SIV vaccines.
- Published in:
- Nature Immunology, 2006, v. 7, n. 1, p. 19, doi. 10.1038/ni1296
- By:
- Publication type:
- Article
HIV vaccine design and the neutralizing antibody problem.
- Published in:
- Nature Immunology, 2004, v. 5, n. 3, p. 233, doi. 10.1038/ni0304-233
- By:
- Publication type:
- Article
T cells versus HIV-1: fighting exhaustion as well as escape.
- Published in:
- Nature Immunology, 2003, v. 4, n. 1, p. 12, doi. 10.1038/ni0103-12
- By:
- Publication type:
- Article
A Dirichlet Process Mixture Model for Non-Ignorable Dropout.
- Published in:
- Bayesian Analysis, 2020, v. 15, n. 4, p. 1139, doi. 10.1214/19-BA1181
- By:
- Publication type:
- Article
Polymorphism characteristics of HIV-1 gp120 and 5 hypervariable regions.
- Published in:
- Turkish Journal of Medical Sciences, 2015, v. 45, n. 1, p. 47, doi. 10.3906/sag-1307-132
- By:
- Publication type:
- Article
Developing an AIDS Vaccine: A Global Public Good.
- Published in:
- 2003
- By:
- Publication type:
- Interview
Relative risk regression for current status data in case-cohort studies.
- Published in:
- Canadian Journal of Statistics, 2011, v. 39, n. 4, p. 557, doi. 10.1002/cjs.10111
- By:
- Publication type:
- Article
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.
- Published in:
- African Journal of Laboratory Medicine, 2021, v. 10, n. 1, p. 1, doi. 10.4102/ajlm.v10i1.1056
- By:
- Publication type:
- Article
Receptor Binding Domain Based HIV Vaccines.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/594109
- By:
- Publication type:
- Article
Including Marginalized Populations in HIV Clinical Trials: A New Role for Nurse-Researchers.
- Published in:
- Policy, Politics & Nursing Practice, 2007, v. 8, n. 4, p. 271, doi. 10.1177/1527154407313466
- By:
- Publication type:
- Article
Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.
- Published in:
- Infectious Diseases & Therapy, 2017, v. 6, n. 3, p. 333, doi. 10.1007/s40121-017-0165-y
- By:
- Publication type:
- Article
Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.
- Published in:
- Infectious Diseases & Therapy, 2017, v. 6, n. 3, p. 303, doi. 10.1007/s40121-017-0166-x
- By:
- Publication type:
- Article
Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.690647
- By:
- Publication type:
- Article
Capturing public interest toward new tools for controlling human immunodeficiency virus (HIV) infection exploiting data from Google Trends.
- Published in:
- Health Informatics Journal, 2019, v. 25, n. 4, p. 1383, doi. 10.1177/1460458218766573
- By:
- Publication type:
- Article
UN AIDS and The Global Fund.
- Published in:
- Journal of Global Health, 2015, v. 5, n. 1, p. 4, doi. 10.7189/jogh.05.010202
- Publication type:
- Article
The Bill and Melinda Gates Foundation.
- Published in:
- Journal of Global Health, 2014, v. 4, n. 2, p. 1, doi. 10.7189/jogh.04.020202
- Publication type:
- Article
The influence of behavioural heterogeneity on the population level effect of potential prophylactic human immunodeficiency virus type 1 vaccines.
- Published in:
- Journal of the Royal Statistical Society: Series A (Statistics in Society), 1998, v. 161, n. 2, p. 209, doi. 10.1111/1467-985X.00100
- By:
- Publication type:
- Article
Statistical issues in phase III human immunodeficiency virus vaccine trial design.
- Published in:
- Journal of the Royal Statistical Society: Series A (Statistics in Society), 1998, v. 161, n. 2, p. 265, doi. 10.1111/1467-985X.00104
- By:
- Publication type:
- Article
Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42906-y
- By:
- Publication type:
- Article